TrialClinical and translational science2020

Making Better Dose Decisions: Using Exposure-Response Modeling to Integrate Efficacy Outcome of Two Phase IIb Clinical Trials of Ubrogepant for Migraine Treatment.

Chi-Chung Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.